Season 2, Ep #3 – A Circuit City Model for 340B Drugs?
Filibusters & Fine Print by AMGA (American Medical Group Association)
Episode notes
HRSA’s new 340B model will test a rebate model for 340B drugs, requiring providers to file for a rebate rather than receiving an upfront discount. The AMGA discusses the ramifications of this change, along with CMS’ plan to accelerate a repayment plan as part of its proposed outpatient rule.
Keywords
healthcareAMGA podcastAMGAhealthcare policyAMGA Filibuster and Fine PrintAMGA Filibusters & Fine Print PodcastFilibusters & Fine Print PodcastAMGA Public Policy PodcastPublic PolicyCMS340B drugCMS repayment plan340B drug discount program